In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Crucell Switzerland AG

Division of Johnson & Johnson
www.bernabiotech.com

Latest From Crucell Switzerland AG

Deals Shaping The Medical Industry, September 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June-August 2014.

BioPharmaceutical Medical Device

CSL's Shortcut from Down Under

CSL Ltd. is moving its flu vaccine from Australia (Fluvax) through the US regulatory process in the hopes of importing its product for the 2007 season. CSL is getting help on the US development from the National Institutes of Allergy and Infectious Diseases. The Australian firm may match Glaxo's fast approval for Fluarix in 2005.
BioPharmaceutical Asia Pacific

Deals (04/2006)

Reviewing 2005: The Top Biopharma Stories

Among our stop stories from 2005: Safety and the FDA: decision by indecision; ahe Plan B kerfuffle; acquisition as the new exit strategy for private biotechs; TLRs-the hottest drug target; pricing revives vaccines; Pfizer's challenges and Genentech's triumphs. Among the predictions for the big stories of 2006: Medicare's impact, the oncology bubble, biogenerics and genomics' revival--via diagnostics.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Swiss Serum & Vaccine Institute
  • Berna Biotech Ltd.
  • Berna Biotech AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Johnson & Johnson
  • Senior Management
  • Kuno Sommer, CEO
    Rolf Gasser, CFO
  • Contact Info
  • Crucell Switzerland AG
    Phone: (41) 31 980 6111
    Rehhagstrasse 79
    Berne, CH-30181
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register